Cube Biotech
Private Company
Funding information not available
Overview
Cube Biotech is a private, revenue-generating tools and services company based in Planegg, Germany. Its core business revolves around its proprietary NativeMP™ technology platform, which includes polymers, kits, and automated plate systems for the stabilization, solubilization, and purification of membrane proteins—a critical yet difficult class of drug targets. The company operates a hybrid model, selling standardized research consumables while also offering custom protein services and bead functionalization, supported by a global reputation evidenced by publications from over 100 institutions.
Technology Platform
NativeMP™ platform featuring novel amphipathic polymers (e.g., SMALP BZ series) and associated kits/plates (PlateX MP™, PureHT™) for the stabilization, solubilization, and purification of membrane proteins in their native lipid environment.
Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive life science research tools market, specifically competing with other providers of membrane protein extraction and stabilization reagents (e.g., different SMALP polymers, amphipols, nanodisc technologies). Competitors range from large reagent distributors to specialized biotech firms. Cube differentiates through its focused NativeMP™ platform, integrated workflow products, and custom service capabilities.